1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Monoclonal Antibody Service Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Reagents 1.2.3 Drugs 1.2.4 Other 1.3 Market by Application 1.3.1 Global Monoclonal Antibody Service Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Diagnostic Laboratories 1.3.3 Research & Academic Laboratories 1.3.4 Pharmaceutical & Biotechnology Companies 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Monoclonal Antibody Service Market Perspective (2016-2027) 2.2 Monoclonal Antibody Service Growth Trends by Regions 2.2.1 Monoclonal Antibody Service Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Monoclonal Antibody Service Historic Market Share by Regions (2016-2021) 2.2.3 Monoclonal Antibody Service Forecasted Market Size by Regions (2022-2027) 2.3 Monoclonal Antibody Service Industry Dynamic 2.3.1 Monoclonal Antibody Service Market Trends 2.3.2 Monoclonal Antibody Service Market Drivers 2.3.3 Monoclonal Antibody Service Market Challenges 2.3.4 Monoclonal Antibody Service Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Monoclonal Antibody Service Players by Revenue 3.1.1 Global Top Monoclonal Antibody Service Players by Revenue (2016-2021) 3.1.2 Global Monoclonal Antibody Service Revenue Market Share by Players (2016-2021) 3.2 Global Monoclonal Antibody Service Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Monoclonal Antibody Service Revenue 3.4 Global Monoclonal Antibody Service Market Concentration Ratio 3.4.1 Global Monoclonal Antibody Service Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Monoclonal Antibody Service Revenue in 2020 3.5 Monoclonal Antibody Service Key Players Head office and Area Served 3.6 Key Players Monoclonal Antibody Service Product Solution and Service 3.7 Date of Enter into Monoclonal Antibody Service Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Monoclonal Antibody Service Breakdown Data by Type 4.1 Global Monoclonal Antibody Service Historic Market Size by Type (2016-2021) 4.2 Global Monoclonal Antibody Service Forecasted Market Size by Type (2022-2027) 5 Monoclonal Antibody Service Breakdown Data by Application 5.1 Global Monoclonal Antibody Service Historic Market Size by Application (2016-2021) 5.2 Global Monoclonal Antibody Service Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Monoclonal Antibody Service Market Size (2016-2027) 6.2 North America Monoclonal Antibody Service Market Size by Type 6.2.1 North America Monoclonal Antibody Service Market Size by Type (2016-2021) 6.2.2 North America Monoclonal Antibody Service Market Size by Type (2022-2027) 6.2.3 North America Monoclonal Antibody Service Market Size by Type (2016-2027) 6.3 North America Monoclonal Antibody Service Market Size by Application 6.3.1 North America Monoclonal Antibody Service Market Size by Application (2016-2021) 6.3.2 North America Monoclonal Antibody Service Market Size by Application (2022-2027) 6.3.3 North America Monoclonal Antibody Service Market Size by Application (2016-2027) 6.4 North America Monoclonal Antibody Service Market Size by Country 6.4.1 North America Monoclonal Antibody Service Market Size by Country (2016-2021) 6.4.2 North America Monoclonal Antibody Service Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Monoclonal Antibody Service Market Size (2016-2027) 7.2 Europe Monoclonal Antibody Service Market Size by Type 7.2.1 Europe Monoclonal Antibody Service Market Size by Type (2016-2021) 7.2.2 Europe Monoclonal Antibody Service Market Size by Type (2022-2027) 7.2.3 Europe Monoclonal Antibody Service Market Size by Type (2016-2027) 7.3 Europe Monoclonal Antibody Service Market Size by Application 7.3.1 Europe Monoclonal Antibody Service Market Size by Application (2016-2021) 7.3.2 Europe Monoclonal Antibody Service Market Size by Application (2022-2027) 7.3.3 Europe Monoclonal Antibody Service Market Size by Application (2016-2027) 7.4 Europe Monoclonal Antibody Service Market Size by Country 7.4.1 Europe Monoclonal Antibody Service Market Size by Country (2016-2021) 7.4.2 Europe Monoclonal Antibody Service Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Monoclonal Antibody Service Market Size (2016-2027) 8.2 Asia-Pacific Monoclonal Antibody Service Market Size by Type 8.2.1 Asia-Pacific Monoclonal Antibody Service Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Monoclonal Antibody Service Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Monoclonal Antibody Service Market Size by Type (2016-2027) 8.3 Asia-Pacific Monoclonal Antibody Service Market Size by Application 8.3.1 Asia-Pacific Monoclonal Antibody Service Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Monoclonal Antibody Service Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Monoclonal Antibody Service Market Size by Application (2016-2027) 8.4 Asia-Pacific Monoclonal Antibody Service Market Size by Region 8.4.1 Asia-Pacific Monoclonal Antibody Service Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Monoclonal Antibody Service Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Monoclonal Antibody Service Market Size (2016-2027) 9.2 Latin America Monoclonal Antibody Service Market Size by Type 9.2.1 Latin America Monoclonal Antibody Service Market Size by Type (2016-2021) 9.2.2 Latin America Monoclonal Antibody Service Market Size by Type (2022-2027) 9.2.3 Latin America Monoclonal Antibody Service Market Size by Type (2016-2027) 9.3 Latin America Monoclonal Antibody Service Market Size by Application 9.3.1 Latin America Monoclonal Antibody Service Market Size by Application (2016-2021) 9.3.2 Latin America Monoclonal Antibody Service Market Size by Application (2022-2027) 9.3.3 Latin America Monoclonal Antibody Service Market Size by Application (2016-2027) 9.4 Latin America Monoclonal Antibody Service Market Size by Country 9.4.1 Latin America Monoclonal Antibody Service Market Size by Country (2016-2021) 9.4.2 Latin America Monoclonal Antibody Service Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Monoclonal Antibody Service Market Size (2016-2027) 10.2 Middle East & Africa Monoclonal Antibody Service Market Size by Type 10.2.1 Middle East & Africa Monoclonal Antibody Service Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Monoclonal Antibody Service Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Monoclonal Antibody Service Market Size by Type (2016-2027) 10.3 Middle East & Africa Monoclonal Antibody Service Market Size by Application 10.3.1 Middle East & Africa Monoclonal Antibody Service Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Monoclonal Antibody Service Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Monoclonal Antibody Service Market Size by Application (2016-2027) 10.4 Middle East & Africa Monoclonal Antibody Service Market Size by Country 10.4.1 Middle East & Africa Monoclonal Antibody Service Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Monoclonal Antibody Service Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Pfizer 11.1.1 Pfizer Company Details 11.1.2 Pfizer Business Overview 11.1.3 Pfizer Monoclonal Antibody Service Introduction 11.1.4 Pfizer Revenue in Monoclonal Antibody Service Business (2016-2021) 11.1.5 Pfizer Recent Development 11.2 Roche 11.2.1 Roche Company Details 11.2.2 Roche Business Overview 11.2.3 Roche Monoclonal Antibody Service Introduction 11.2.4 Roche Revenue in Monoclonal Antibody Service Business (2016-2021) 11.2.5 Roche Recent Development 11.3 Eli Lilly 11.3.1 Eli Lilly Company Details 11.3.2 Eli Lilly Business Overview 11.3.3 Eli Lilly Monoclonal Antibody Service Introduction 11.3.4 Eli Lilly Revenue in Monoclonal Antibody Service Business (2016-2021) 11.3.5 Eli Lilly Recent Development 11.4 Bayer 11.4.1 Bayer Company Details 11.4.2 Bayer Business Overview 11.4.3 Bayer Monoclonal Antibody Service Introduction 11.4.4 Bayer Revenue in Monoclonal Antibody Service Business (2016-2021) 11.4.5 Bayer Recent Development 11.5 Amgen 11.5.1 Amgen Company Details 11.5.2 Amgen Business Overview 11.5.3 Amgen Monoclonal Antibody Service Introduction 11.5.4 Amgen Revenue in Monoclonal Antibody Service Business (2016-2021) 11.5.5 Amgen Recent Development 11.6 Sanofi-Aventis 11.6.1 Sanofi-Aventis Company Details 11.6.2 Sanofi-Aventis Business Overview 11.6.3 Sanofi-Aventis Monoclonal Antibody Service Introduction 11.6.4 Sanofi-Aventis Revenue in Monoclonal Antibody Service Business (2016-2021) 11.6.5 Sanofi-Aventis Recent Development 11.7 Johnson & Johnson 11.7.1 Johnson & Johnson Company Details 11.7.2 Johnson & Johnson Business Overview 11.7.3 Johnson & Johnson Monoclonal Antibody Service Introduction 11.7.4 Johnson & Johnson Revenue in Monoclonal Antibody Service Business (2016-2021) 11.7.5 Johnson & Johnson Recent Development 11.8 Novo Nordisk 11.8.1 Novo Nordisk Company Details 11.8.2 Novo Nordisk Business Overview 11.8.3 Novo Nordisk Monoclonal Antibody Service Introduction 11.8.4 Novo Nordisk Revenue in Monoclonal Antibody Service Business (2016-2021) 11.8.5 Novo Nordisk Recent Development 11.9 Merck 11.9.1 Merck Company Details 11.9.2 Merck Business Overview 11.9.3 Merck Monoclonal Antibody Service Introduction 11.9.4 Merck Revenue in Monoclonal Antibody Service Business (2016-2021) 11.9.5 Merck Recent Development 11.10 Abbott Laboratories 11.10.1 Abbott Laboratories Company Details 11.10.2 Abbott Laboratories Business Overview 11.10.3 Abbott Laboratories Monoclonal Antibody Service Introduction 11.10.4 Abbott Laboratories Revenue in Monoclonal Antibody Service Business (2016-2021) 11.10.5 Abbott Laboratories Recent Development 11.11 GSK 11.11.1 GSK Company Details 11.11.2 GSK Business Overview 11.11.3 GSK Monoclonal Antibody Service Introduction 11.11.4 GSK Revenue in Monoclonal Antibody Service Business (2016-2021) 11.11.5 GSK Recent Development 11.12 BMS 11.12.1 BMS Company Details 11.12.2 BMS Business Overview 11.12.3 BMS Monoclonal Antibody Service Introduction 11.12.4 BMS Revenue in Monoclonal Antibody Service Business (2016-2021) 11.12.5 BMS Recent Development 11.13 Alexion 11.13.1 Alexion Company Details 11.13.2 Alexion Business Overview 11.13.3 Alexion Monoclonal Antibody Service Introduction 11.13.4 Alexion Revenue in Monoclonal Antibody Service Business (2016-2021) 11.13.5 Alexion Recent Development 11.14 UCB 11.14.1 UCB Company Details 11.14.2 UCB Business Overview 11.14.3 UCB Monoclonal Antibody Service Introduction 11.14.4 UCB Revenue in Monoclonal Antibody Service Business (2016-2021) 11.14.5 UCB Recent Development 11.15 Seattle Genetics 11.15.1 Seattle Genetics Company Details 11.15.2 Seattle Genetics Business Overview 11.15.3 Seattle Genetics Monoclonal Antibody Service Introduction 11.15.4 Seattle Genetics Revenue in Monoclonal Antibody Service Business (2016-2021) 11.15.5 Seattle Genetics Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Monoclonal Antibody Service Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Reagents Table 3. Key Players of Drugs Table 4. Key Players of Other Table 5. Global Monoclonal Antibody Service Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 6. Global Monoclonal Antibody Service Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 7. Global Monoclonal Antibody Service Market Size by Regions (2016-2021) & (US$ Million) Table 8. Global Monoclonal Antibody Service Market Share by Regions (2016-2021) Table 9. Global Monoclonal Antibody Service Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 10. Global Monoclonal Antibody Service Market Share by Regions (2022-2027) Table 11. Monoclonal Antibody Service Market Trends Table 12. Monoclonal Antibody Service Market Drivers Table 13. Monoclonal Antibody Service Market Challenges Table 14. Monoclonal Antibody Service Market Restraints Table 15. Global Monoclonal Antibody Service Revenue by Players (2016-2021) & (US$ Million) Table 16. Global Monoclonal Antibody Service Market Share by Players (2016-2021) Table 17. Global Top Monoclonal Antibody Service Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Monoclonal Antibody Service as of 2020) Table 18. Ranking of Global Top Monoclonal Antibody Service Companies by Revenue (US$ Million) in 2020 Table 19. Global 5 Largest Players Market Share by Monoclonal Antibody Service Revenue (CR5 and HHI) & (2016-2021) Table 20. Key Players Headquarters and Area Served Table 21. Key Players Monoclonal Antibody Service Product Solution and Service Table 22. Date of Enter into Monoclonal Antibody Service Market Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Global Monoclonal Antibody Service Market Size by Type (2016-2021) (US$ Million) Table 25. Global Monoclonal Antibody Service Revenue Market Share by Type (2016-2021) Table 26. Global Monoclonal Antibody Service Forecasted Market Size by Type (2022-2027) (US$ Million) Table 27. Global Monoclonal Antibody Service Revenue Market Share by Type (2022-2027) & (US$ Million) Table 28. Global Monoclonal Antibody Service Market Size Share by Application (2016-2021) & (US$ Million) Table 29. Global Monoclonal Antibody Service Revenue Market Share by Application (2016-2021) Table 30. Global Monoclonal Antibody Service Forecasted Market Size by Application (2022-2027) (US$ Million) Table 31. Global Monoclonal Antibody Service Revenue Market Share by Application (2022-2027) & (US$ Million) Table 32. North America Monoclonal Antibody Service Market Size by Type (2016-2021) (US$ Million) Table 33. North America Monoclonal Antibody Service Market Size by Type (2022-2027) & (US$ Million) Table 34. North America Monoclonal Antibody Service Market Size by Application (2016-2021) (US$ Million) Table 35. North America Monoclonal Antibody Service Market Size by Application (2022-2027) & (US$ Million) Table 36. North America Monoclonal Antibody Service Market Size by Country (2016-2021) & (US$ Million) Table 37. North America Monoclonal Antibody Service Market Size by Country (2022-2027) & (US$ Million) Table 38. Europe Monoclonal Antibody Service Market Size by Type (2016-2021) (US$ Million) Table 39. Europe Monoclonal Antibody Service Market Size by Type (2022-2027) & (US$ Million) Table 40. Europe Monoclonal Antibody Service Market Size by Application (2016-2021) (US$ Million) Table 41. Europe Monoclonal Antibody Service Market Size by Application (2022-2027) & (US$ Million) Table 42. Europe Monoclonal Antibody Service Market Size by Country (2016-2021) & (US$ Million) Table 43. Europe Monoclonal Antibody Service Market Size by Country (2022-2027) & (US$ Million) Table 44. Asia-Pacific Monoclonal Antibody Service Market Size by Type (2016-2021) (US$ Million) Table 45. Asia-Pacific Monoclonal Antibody Service Market Size by Type (2022-2027) & (US$ Million) Table 46. Asia-Pacific Monoclonal Antibody Service Market Size by Application (2016-2021) (US$ Million) Table 47. Asia-Pacific Monoclonal Antibody Service Market Size by Application (2022-2027) & (US$ Million) Table 48. Asia-Pacific Monoclonal Antibody Service Market Size by Region (2016-2021) & (US$ Million) Table 49. Asia-Pacific Monoclonal Antibody Service Market Size by Region (2022-2027) & (US$ Million) Table 50. Latin America Monoclonal Antibody Service Market Size by Type (2016-2021) (US$ Million) Table 51. Latin America Monoclonal Antibody Service Market Size by Type (2022-2027) & (US$ Million) Table 52. Latin America Monoclonal Antibody Service Market Size by Application (2016-2021) (US$ Million) Table 53. Latin America Monoclonal Antibody Service Market Size by Application (2022-2027) & (US$ Million) Table 54. Latin America Monoclonal Antibody Service Market Size by Country (2016-2021) & (US$ Million) Table 55. Latin America Monoclonal Antibody Service Market Size by Country (2022-2027) & (US$ Million) Table 56. Middle East & Africa Monoclonal Antibody Service Market Size by Type (2016-2021) (US$ Million) Table 57. Middle East & Africa Monoclonal Antibody Service Market Size by Type (2022-2027) & (US$ Million) Table 58. Middle East & Africa Monoclonal Antibody Service Market Size by Application (2016-2021) (US$ Million) Table 59. Middle East & Africa Monoclonal Antibody Service Market Size by Application (2022-2027) & (US$ Million) Table 60. Middle East & Africa Monoclonal Antibody Service Market Size by Country (2016-2021) & (US$ Million) Table 61. Middle East & Africa Monoclonal Antibody Service Market Size by Country (2022-2027) & (US$ Million) Table 62. Pfizer Company Details Table 63. Pfizer Business Overview Table 64. Pfizer Monoclonal Antibody Service Product Table 65. Pfizer Revenue in Monoclonal Antibody Service Business (2016-2021) & (US$ Million) Table 66. Pfizer Recent Development Table 67. Roche Company Details Table 68. Roche Business Overview Table 69. Roche Monoclonal Antibody Service Product Table 70. Roche Revenue in Monoclonal Antibody Service Business (2016-2021) & (US$ Million) Table 71. Roche Recent Development Table 72. Eli Lilly Company Details Table 73. Eli Lilly Business Overview Table 74. Eli Lilly Monoclonal Antibody Service Product Table 75. Eli Lilly Revenue in Monoclonal Antibody Service Business (2016-2021) & (US$ Million) Table 76. Eli Lilly Recent Development Table 77. Bayer Company Details Table 78. Bayer Business Overview Table 79. Bayer Monoclonal Antibody Service Product Table 80. Bayer Revenue in Monoclonal Antibody Service Business (2016-2021) & (US$ Million) Table 81. Bayer Recent Development Table 82. Amgen Company Details Table 83. Amgen Business Overview Table 84. Amgen Monoclonal Antibody Service Product Table 85. Amgen Revenue in Monoclonal Antibody Service Business (2016-2021) & (US$ Million) Table 86. Amgen Recent Development Table 87. Sanofi-Aventis Company Details Table 88. Sanofi-Aventis Business Overview Table 89. Sanofi-Aventis Monoclonal Antibody Service Product Table 90. Sanofi-Aventis Revenue in Monoclonal Antibody Service Business (2016-2021) & (US$ Million) Table 91. Sanofi-Aventis Recent Development Table 92. Johnson & Johnson Company Details Table 93. Johnson & Johnson Business Overview Table 94. Johnson & Johnson Monoclonal Antibody Service Product Table 95. Johnson & Johnson Revenue in Monoclonal Antibody Service Business (2016-2021) & (US$ Million) Table 96. Johnson & Johnson Recent Development Table 97. Novo Nordisk Company Details Table 98. Novo Nordisk Business Overview Table 99. Novo Nordisk Revenue in Monoclonal Antibody Service Business (2016-2021) & (US$ Million) Table 100. Novo Nordisk Recent Development Table 101. Merck Company Details Table 102. Merck Business Overview Table 103. Merck Monoclonal Antibody Service Product Table 104. Merck Revenue in Monoclonal Antibody Service Business (2016-2021) & (US$ Million) Table 105. Merck Recent Development Table 106. Abbott Laboratories Company Details Table 107. Abbott Laboratories Business Overview Table 108. Abbott Laboratories Monoclonal Antibody Service Product Table 109. Abbott Laboratories Revenue in Monoclonal Antibody Service Business (2016-2021) & (US$ Million) Table 110. Abbott Laboratories Recent Development Table 111. GSK Company Details Table 112. GSK Business Overview Table 113. GSK Monoclonal Antibody Service Product Table 114. GSK Revenue in Monoclonal Antibody Service Business (2016-2021) & (US$ Million) Table 115. GSK Recent Development Table 116. BMS Company Details Table 117. BMS Business Overview Table 118. BMS Monoclonal Antibody Service Product Table 119. BMS Revenue in Monoclonal Antibody Service Business (2016-2021) & (US$ Million) Table 120. BMS Recent Development Table 121. Alexion Company Details Table 122. Alexion Business Overview Table 123. Alexion Monoclonal Antibody Service Product Table 124. Alexion Revenue in Monoclonal Antibody Service Business (2016-2021) & (US$ Million) Table 125. Alexion Recent Development Table 126. UCB Company Details Table 127. UCB Business Overview Table 128. UCB Monoclonal Antibody Service Product Table 129. UCB Revenue in Monoclonal Antibody Service Business (2016-2021) & (US$ Million) Table 130. UCB Recent Development Table 131. Seattle Genetics Company Details Table 132. Seattle Genetics Business Overview Table 133. Seattle Genetics Monoclonal Antibody Service Product Table 134. Seattle Genetics Revenue in Monoclonal Antibody Service Business (2016-2021) & (US$ Million) Table 135. Seattle Genetics Recent Development Table 136. Research Programs/Design for This Report Table 137. Key Data Information from Secondary Sources Table 138. Key Data Information from Primary Sources List of Figures Figure 1. Global Monoclonal Antibody Service Market Share by Type: 2020 VS 2027 Figure 2. Reagents Features Figure 3. Drugs Features Figure 4. Other Features Figure 5. Global Monoclonal Antibody Service Market Share by Application: 2020 VS 2027 Figure 6. Diagnostic Laboratories Case Studies Figure 7. Research & Academic Laboratories Case Studies Figure 8. Pharmaceutical & Biotechnology Companies Case Studies Figure 9. Monoclonal Antibody Service Report Years Considered Figure 10. Global Monoclonal Antibody Service Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 11. Global Monoclonal Antibody Service Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 12. Global Monoclonal Antibody Service Market Share by Regions: 2020 VS 2027 Figure 13. Global Monoclonal Antibody Service Market Share by Regions (2022-2027) Figure 14. Global Monoclonal Antibody Service Market Share by Players in 2020 Figure 15. Global Top Monoclonal Antibody Service Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Monoclonal Antibody Service as of 2020 Figure 16. The Top 10 and 5 Players Market Share by Monoclonal Antibody Service Revenue in 2020 Figure 17. Global Monoclonal Antibody Service Revenue Market Share by Type (2016-2021) Figure 18. Global Monoclonal Antibody Service Revenue Market Share by Type (2022-2027) Figure 19. North America Monoclonal Antibody Service Market Size YoY Growth (2016-2027) & (US$ Million) Figure 20. North America Monoclonal Antibody Service Market Share by Type (2016-2027) Figure 21. North America Monoclonal Antibody Service Market Share by Application (2016-2027) Figure 22. North America Monoclonal Antibody Service Market Share by Country (2016-2027) Figure 23. United States Monoclonal Antibody Service Market Size YoY Growth (2016-2027) & (US$ Million) Figure 24. Canada Monoclonal Antibody Service Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Europe Monoclonal Antibody Service Market Size YoY Growth (2016-2027) & (US$ Million) Figure 26. Europe Monoclonal Antibody Service Market Share by Type (2016-2027) Figure 27. Europe Monoclonal Antibody Service Market Share by Application (2016-2027) Figure 28. Europe Monoclonal Antibody Service Market Share by Country (2016-2027) Figure 29. Germany Monoclonal Antibody Service Market Size YoY Growth (2016-2027) & (US$ Million) Figure 30. France Monoclonal Antibody Service Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. U.K. Monoclonal Antibody Service Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. Italy Monoclonal Antibody Service Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Russia Monoclonal Antibody Service Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Nordic Monoclonal Antibody Service Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Asia-Pacific Monoclonal Antibody Service Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Asia-Pacific Monoclonal Antibody Service Market Share by Type (2016-2027) Figure 37. Asia-Pacific Monoclonal Antibody Service Market Share by Application (2016-2027) Figure 38. Asia-Pacific Monoclonal Antibody Service Market Share by Region (2016-2027) Figure 39. China Monoclonal Antibody Service Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. Japan Monoclonal Antibody Service Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. South Korea Monoclonal Antibody Service Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. Southeast Asia Monoclonal Antibody Service Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. India Monoclonal Antibody Service Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Australia Monoclonal Antibody Service Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Latin America Monoclonal Antibody Service Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Latin America Monoclonal Antibody Service Market Share by Type (2016-2027) Figure 47. Latin America Monoclonal Antibody Service Market Share by Application (2016-2027) Figure 48. Latin America Monoclonal Antibody Service Market Share by Country (2016-2027) Figure 49. Mexico Monoclonal Antibody Service Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Brazil Monoclonal Antibody Service Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Middle East & Africa Monoclonal Antibody Service Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. Middle East & Africa Monoclonal Antibody Service Market Share by Type (2016-2027) Figure 53. Middle East & Africa Monoclonal Antibody Service Market Share by Application (2016-2027) Figure 54. Middle East & Africa Monoclonal Antibody Service Market Share by Country (2016-2027) Figure 55. Turkey Monoclonal Antibody Service Market Size YoY Growth (2016-2027) & (US$ Million) Figure 56. Saudi Arabia Monoclonal Antibody Service Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. UAE Monoclonal Antibody Service Market Size YoY Growth (2016-2027) & (US$ Million) Figure 58. Pfizer Revenue Growth Rate in Monoclonal Antibody Service Business (2016-2021) Figure 59. Roche Revenue Growth Rate in Monoclonal Antibody Service Business (2016-2021) Figure 60. Eli Lilly Revenue Growth Rate in Monoclonal Antibody Service Business (2016-2021) Figure 61. Bayer Revenue Growth Rate in Monoclonal Antibody Service Business (2016-2021) Figure 62. Amgen Revenue Growth Rate in Monoclonal Antibody Service Business (2016-2021) Figure 63. Sanofi-Aventis Revenue Growth Rate in Monoclonal Antibody Service Business (2016-2021) Figure 64. Johnson & Johnson Revenue Growth Rate in Monoclonal Antibody Service Business (2016-2021) Figure 65. Novo Nordisk Revenue Growth Rate in Monoclonal Antibody Service Business (2016-2021) Figure 66. Merck Revenue Growth Rate in Monoclonal Antibody Service Business (2016-2021) Figure 67. Abbott Laboratories Revenue Growth Rate in Monoclonal Antibody Service Business (2016-2021) Figure 68. GSK Revenue Growth Rate in Monoclonal Antibody Service Business (2016-2021) Figure 69. BMS Revenue Growth Rate in Monoclonal Antibody Service Business (2016-2021) Figure 70. Alexion Revenue Growth Rate in Monoclonal Antibody Service Business (2016-2021) Figure 71. UCB Revenue Growth Rate in Monoclonal Antibody Service Business (2016-2021) Figure 72. Seattle Genetics Revenue Growth Rate in Monoclonal Antibody Service Business (2016-2021) Figure 73. Bottom-up and Top-down Approaches for This Report Figure 74. Data Triangulation Figure 75. Key Executives Interviewed

Pfizer Roche Eli Lilly Bayer Amgen Sanofi-Aventis Johnson & Johnson Novo Nordisk Merck Abbott Laboratories GSK BMS Alexion UCB Seattle Genetics